226 related articles for article (PubMed ID: 37534643)
21. [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].
Aridoğan BC; Kaya S; Savaş S; Cetin ES; Akkuş S; Demirci M
Mikrobiyol Bul; 2008 Oct; 42(4):669-74. PubMed ID: 19149089
[TBL] [Abstract][Full Text] [Related]
22. Elevated levels of Metrnl in rheumatoid arthritis: Association with disease activity.
Zhang S; Lei Y; Sun T; Gao Z; Li Z; Shen H
Cytokine; 2022 Nov; 159():156026. PubMed ID: 36084603
[TBL] [Abstract][Full Text] [Related]
23. [Significance and diagnostic value of synovial fluid anti-cyclic citrullinated peptide antibody and anti-mutated citrullinated vimentin antibodies in patients with serum negative rheumatoid arthritis].
Qu SJ; Ye H; Jia RL; Li ZG
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):933-936. PubMed ID: 27987492
[TBL] [Abstract][Full Text] [Related]
24. [Significance of citrullinated collagen type II and its antibodies in rheumatoid arthritis].
Tian X; Bi LQ; Li ZG
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(33):2334-8. PubMed ID: 17156630
[TBL] [Abstract][Full Text] [Related]
25. Anti-CCP and antikeratin antibodies in rheumatoid arthritis, primary Sjögren's syndrome, and Wegener's granulomatosis.
Kamali S; Polat NG; Kasapoglu E; Gul A; Ocal L; Aral O; Konice M; Badur S; Inanc M
Clin Rheumatol; 2005 Nov; 24(6):673-6. PubMed ID: 15926038
[TBL] [Abstract][Full Text] [Related]
26. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis.
Rantapää-Dahlqvist S; de Jong BA; Berglin E; Hallmans G; Wadell G; Stenlund H; Sundin U; van Venrooij WJ
Arthritis Rheum; 2003 Oct; 48(10):2741-9. PubMed ID: 14558078
[TBL] [Abstract][Full Text] [Related]
27. Comparison of anti-agalactosyl IgG antibodies, rheumatoid factors, and anti-cyclic citrullinated peptide antibodies in the differential diagnosis of rheumatoid arthritis and its mimics.
Lu MC; Hsieh SC; Lai NS; Li KJ; Wu CH; Yu CL
Clin Exp Rheumatol; 2007; 25(5):716-21. PubMed ID: 18078619
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of IgA class antibodies to cyclic citrullinated peptide (anti-CCP) in patients with primary Sjögren's syndrome, and its association to clinical manifestations.
Haga HJ; Andersen DT; Peen E
Clin Rheumatol; 2011 Mar; 30(3):369-72. PubMed ID: 21234630
[TBL] [Abstract][Full Text] [Related]
29. Comparison of anti-mutated citrullinated vimentin, anti-cyclic citrullinated peptides, anti-glucose-6-phosphate isomerase and anti-keratin antibodies and rheumatoid factor in the diagnosis of rheumatoid arthritis in Chinese patients.
Zhu T; Feng L
Int J Rheum Dis; 2013 Apr; 16(2):157-61. PubMed ID: 23773638
[TBL] [Abstract][Full Text] [Related]
30. Antibodies to Cyclic Citrullinated Peptides in Patients With Juvenile Idiopathic Arthritis and Patients With Rheumatoid Arthritis: Shared Expression of the Inherently Autoreactive 9G4 Idiotype.
Peckham H; Cambridge G; Bourke L; Sen D; Radziszewska A; Leandro M; Ioannou Y
Arthritis Rheumatol; 2017 Jul; 69(7):1387-1395. PubMed ID: 28380667
[TBL] [Abstract][Full Text] [Related]
31. Antibody Responses to Epstein-Barr Virus in the Preclinical Period of Rheumatoid Arthritis Suggest the Presence of Increased Viral Reactivation Cycles.
Fechtner S; Berens H; Bemis E; Johnson RL; Guthridge CJ; Carlson NE; Demoruelle MK; Harley JB; Edison JD; Norris JA; Robinson WH; Deane KD; James JA; Holers VM
Arthritis Rheumatol; 2022 Apr; 74(4):597-603. PubMed ID: 34605217
[TBL] [Abstract][Full Text] [Related]
32. Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis.
Low JM; Chauhan AK; Kietz DA; Daud U; Pepmueller PH; Moore TL
J Rheumatol; 2004 Sep; 31(9):1829-33. PubMed ID: 15338508
[TBL] [Abstract][Full Text] [Related]
33. Anti-cyclic citrullinated peptide antibody isotypes in rheumatoid arthritis: association with disease duration, rheumatoid factor production and the presence of shared epitope.
Lakos G; Soós L; Fekete A; Szabó Z; Zeher M; Horváth IF; Dankó K; Kapitány A; Gyetvai A; Szegedi G; Szekanecz Z
Clin Exp Rheumatol; 2008; 26(2):253-60. PubMed ID: 18565246
[TBL] [Abstract][Full Text] [Related]
34. GITRL is associated with increased autoantibody production in patients with rheumatoid arthritis.
Li L; Wen W; Jia R; Li Y; Liu X; Sun X; Li Z
Clin Rheumatol; 2016 Sep; 35(9):2195-202. PubMed ID: 27098050
[TBL] [Abstract][Full Text] [Related]
35. Frequency of serological markers of rheumatoid arthritis in patients with IgA anti-β2 glycoprotein I antibodies.
Melayah S; Ghozzi M; Mankaï A; Mechi F; Ghedira I
J Clin Lab Anal; 2022 Jul; 36(7):e24537. PubMed ID: 35666694
[TBL] [Abstract][Full Text] [Related]
36. Elevated levels of anti-carbamylated protein antibody in patients with rheumatoid arthritis: association with disease activity and bone destruction.
Zhang B; Lei Y; Li X; Gao Z; Xia L; Lu J; Shen H
J Investig Med; 2020 Aug; 68(6):1186-1192. PubMed ID: 32690598
[TBL] [Abstract][Full Text] [Related]
37. IgG, IgA, IgM antibodies to a viral citrullinated peptide in patients affected by rheumatoid arthritis, chronic arthritides and connective tissue disorders.
Anzilotti C; Riente L; Pratesi F; Chimenti D; Delle Sedie A; Bombardieri S; Migliorini P
Rheumatology (Oxford); 2007 Oct; 46(10):1579-82. PubMed ID: 17717033
[TBL] [Abstract][Full Text] [Related]
38. [Clinical significance of serum C-C chemokine ligand 19 levels in patients with rheumatoid arthritis].
Shi LJ; Li JH; Hu FL; Li M; Zhang J; Li JT; Li ZG
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Aug; 48(4):667-671. PubMed ID: 29263510
[TBL] [Abstract][Full Text] [Related]
39. Serologic profile and clinical markers of Sjögren syndrome in patients with rheumatoid arthritis.
Oliveira HF; de Souza TR; Carvalho CN; Duarte A; Carvalho AT; Leão JC; Gueiros LA
Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Jun; 119(6):628-35. PubMed ID: 25956216
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.
Matsui T; Shimada K; Ozawa N; Hayakawa H; Hagiwara F; Nakayama H; Sugii S; Ozawa Y; Tohma S
J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
